GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Impact BioMedical Inc (AMEX:IBO) » Definitions » Notes Receivable

IBO (Impact BioMedical) Notes Receivable : $0.20 Mil (As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Impact BioMedical Notes Receivable?

Impact BioMedical's Notes Receivable for the quarter that ended in Mar. 2025 was $0.20 Mil.

Impact BioMedical's quarterly Notes Receivable increased from Sep. 2024 ($0.14 Mil) to Dec. 2024 ($0.18 Mil) and increased from Dec. 2024 ($0.18 Mil) to Mar. 2025 ($0.20 Mil).

Impact BioMedical's annual Notes Receivable increased from Dec. 2022 ($0.02 Mil) to Dec. 2023 ($0.20 Mil) but then declined from Dec. 2023 ($0.20 Mil) to Dec. 2024 ($0.18 Mil).


Impact BioMedical Notes Receivable Historical Data

The historical data trend for Impact BioMedical's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Impact BioMedical Notes Receivable Chart

Impact BioMedical Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Notes Receivable
Get a 7-Day Free Trial - 0.20 0.02 0.20 0.18

Impact BioMedical Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.14 0.14 0.18 0.20

Impact BioMedical Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Impact BioMedical Notes Receivable Related Terms

Thank you for viewing the detailed overview of Impact BioMedical's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Impact BioMedical Business Description

Traded in Other Exchanges
N/A
Address
1400 Broadfield Boulevard, Suite 130, Houston, TX, USA, 77084
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.

Impact BioMedical Headlines